Embryonic stem-cell culture as a tool for developmental cell biology

Already registered? Login

-->

Home |

Search hES cell database |

Scientific Information |

Community Information |

The Stem Cell Resource |

Meetings, Societies and Journals |

Archives |

All Archived Articles |

Novak Article |

Wisconsin Alumni Research Foundation changes stem cell policies |

Southern CA Stem Cell Scientists Sound Off |

Stem cells untethered |

Catherine Verfaillie Under Scrutiny For Erroneous Duplication of Data |

Human Stem Cells Battle Degenerative Brain Diseases |

Stem Cell Community in Science |

The Stem Cell Resource |

Adult neural stem cells show promise for Huntington's Disease |

Human ES Cells (hESCs) Acquire Tumorigenic Characteristics With Prolonged Culture |

Featured Review: Genetic and Epigenetic Regulators of Pluripotency |

A Double Stranded RNA Binding Protein, Dgcr8, is Essential for microRNA (miRNA) Processing and Differentiation in Mouse Embryonic Stem Cells (ESC) |

Verfaillie’s seat getting hotter and hotter ! |

Researchers note certain stem cell studies extremely difficult to replicate, negative implications for the future of stem cell biology. |

WARF Patent Challenges Upheld |

Groups Target Stem Cell Patents |

Proposition 71 and CIRM-assessing the return on investment |

Can we develop ethically universal embryonic stem-cell lines? |

Deconstructing the Claimed AIDS Cure |

Federal Government Rules Against Wisconsin Stem Cell Patents: |

NEWS OF THE WEEK : U.S. Patent Office Casts Doubt on Wisconsin Stem Cell Patents |

Stem Cell Issue Moves Up The US Agenda |

US tosses out patents on three Wisconsin stem cell lines |

Chinese network to start trials of spinal surgery |

Patenting the obvious? |

Stem Cell President Quits After Acrimonious Meeting (Science) |

California Stem Cell Scientists Applaud CIRM Funding |

California Stem Cell Proposition 71 Upheld After Appeal |

$75 MLLION BOOST FOR CALIFORNIA STEM CELL SCIENTISTS |

HESC Derived Endothelial Cells Form Blood Vessels Long-Term |

Patent Watch: Key stem-cell patents rejected |

Research Highlight : Stem cells: Sharing common factors for self-renewal |

Adult neural stem cells show promise for Huntington's Disease |

Simple Switch Turns Cells Embryonic |

Monkey stem cells cloned: Advance could renew enthusiasm for the field |

News and Views: Stem cells: Recycling the abnormal |

Embryonic stem-cell culture as a tool for developmental cell biology |

NEWS OF THE WEEK STEM CELLS: Reprogramming, Take Two |

NEWS OF THE WEEK STEM CELLS:_Teams Reprogram Differentiated Cells--Without Eggs |

SCIENCE LETTERS: Adult Versus Embryonic Stem Cells: Treatments |

Human ESC derived Dopamine Neurons Improve PD Rats |

Flawed data in multipotent cell study |

From skin cell to stem cell |

Cultured ES Cells Come Unstuck |

Fertilized eggs reprogram adult-cell genomes |

Research Highlight: Stem cells: Introducing the next generation |

Stem cells from cloned primates |

Stem cells created from cloned monkey cells: U.S. scientists move step closer to human therapeutic cloning |

Activated eggs offer route to stem cells |

Turning skin into embryonic stem cells |

Oz stem cell clinic turns to diseased embryos |

Teams trail genes for human ‘stemness’ |

Neural stem cells for Parkinson's disease: To protect and repair |

“Stem-cell fraudster ‘is working in Thailand’ : Woo Suk Hwang may be back in the cloning lab. |

King of the stem cells |

Stem cells by any other name: The US registry formerly known as 'embryonic' |

Revamped guidelines aim to keep pace with stem cell advances |

Generation of pluripotent stem cells from adult human testis |

When Embryonic Stem Cell Lines Fail to Meet Consent Standards |

Falsification Charge Highlights Image-Manipulation Standards |

Short cut to cell replacement |

Pluripotency factors flick the switch |

Republicans at odds over human embryo research: Stem cells divide McCain's camp |

Last-Ditch Effort to Save Center at Vanguard of Stem Cell Research |

Stem-cell law goes to the polls |

NEWS OF THE WEEK: BIOETHICS: U.K. Approves New Embryo Law |

Safer Stem Cells |

Australia grants license for therapeutic cloning |

European Union and NIH Collaborate |

SCIENCE AND THE ELECTION: Obama Victory Raises Hopes for New Policies, Bigger Budgets |

From stem cells to germ cells and back again |

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes |

FEATURE ARTICLE: Oligopotent stem cells are distributed throughout the mammalian ocular surface |

Stem-cell futures: In the changed political climate, US agencies can provide a new kind of leadership |

News Feature: Stem cells drafted for war on wounds |

Research Highlights: Exogenous aids to reprogramming and self-renewal |

Stem cell society urges action on bogus clinics |

Reprogrammed skin cells provide testing ground for new drugs |

Stem cells: Induced pluripotent stem cells from a spinal muscular atrophy patient |

Breakthrough of the Year: Reprogramming Cells |

Correspondence: Stem cell transplants: the power of peer-to-peer |

Commentary: Offshore stem cell treatments |

Adult monkey cells reprogrammed: Mouse, human and monkey cells can be induced to pluripotency |

OBAMA TRANSITION A Fresh Start for Embryonic Stem Cells |

Salary for CIRM head despite deficit |

Challenges anticipated in removal of stem cell restrictions |

Religious leaders weigh in on current and future embryo research |

Green light for UK stem-cell trial |

Human embryonic stem cell trial wins approval |

MS stem-cell trial shows promise |

Celebration and Concern Over U.S. Trial of Embryonic Stem Cells |

When is a stem cell specified? |

New Administration Likely to Bring Change to Stem Cell Research |

Financial Crisis: Stem Cell Institute Looks for New Ways to Raise Cash |

Osiris seals billion-dollar deal with Genzyme for cell therapy |

Stem cells caught in morality clause |

Reprogramming Therapeutics: iPS Cell Prospects for Neurodegenerative Disease |

Stem cells ready for prime time: US regulatory agency gives the go-ahead for first clinical trials of a human embryonic stem-cell treatment. |

Stem-cell transplant wipes out HIV: But the treatment is too risky to help most who are infected with the virus |

Virus-free pluripotency for human cells: Stem-cell advance could bring tailored treatments closer |

First FDA-approved embryonic stem cell trial |

US stem cell climate improves, raising concerns elsewhere |

F.D.A. Approves a Stem Cell Trial |

Transcript: Obama's Remarks on Stem Cell Research |

News Analysis Rethink Stem Cells? Science Already Has |

Obama Is Leaving Some Stem Cell Issues to Congress By: Sheryl Gay Stolberg |

Obama Lifts Bush’s Strict Limits on Stem Cell Research |

Obama reins in signing statements |

Obama ends stem cell funding ban |

Obama overturns Bush policy on stem cells |

Obama Stem Cell Decision Called 'Deadly Executive Order |

Obama Lifts Stem Cell Ban but Opens Debate on Embryo Creation |

President Obama Reverses Bush's Stem Cell Research Ban |

The Politics Behind Obama's Embryonic Stem Cell Research Decision |

Obama Lifts Embryonic Stem Cell Research Ban, Spurring Blogger Debate Bloggers take on Obama's move on stem cells |

Obama overturns stem-cell ban |

YESTERDAY AT THE WHITE HOUSE |

Geron gets green light for human trial of ES cell–derived product |

Stem cell clinical trials must be closely monitored |

Companies say clinical trials, product launches, coming up, seek investors |

Unregulated stem cell transplant causes tumours |

Human embryonic stem cells hit a nerve |

China's policies on stem cell research: an opportunity for international collaborations |

Prospects: Stem cell recruits |

OBAMA EXECUTIVE ORDER: For Congress and NIH, Headaches Ahead on Stem Cells |

OBAMA EXECUTIVE ORDER: For Congress and NIH, Headaches Ahead on Stem Cells |

AUSTRALIA: Stem Cell Center Looks to Recast Itself in Supporting Role |

Monitoring and Regulating Offshore Stem Cell Clinics |

Stem cell shifts: Skin cells are claimed as a new source of stem cells. |

Embryonic Education |

Meet the inlaws: Embryonic stem cell derivatives meet the immune system |

A stem cell ban is lifted, but some states see a heavy backlash |

Overcoming Opposition, Brazil Banks on Stem Cells |

Morality and human embryo research: Introduction to the Talking Point on morality and human embryo research |

Embryonic human persons: Talking Point on morality and human embryo research |

Destroying unwanted embryos in research |

Multiple sclerosis: Stem cell transplants ameliorate neurological deficits in multiple sclerosis |

Stem cells: Low-risk reprogramming |

Reprogramming to pluripotency without genetic engineering |

Stem-cell treatments for spinal-cord injury may be worth the risk |

Stem cells: Fast and furious |

Fake Facebook pages spin web of deceit |

Still strict on stem cells |

Obama's stem cell move |

The pendulum swung. President Barack Obama removes restrictions on stem-cell research, but are expectations now too high? |

A History Lesson for Stem Cells |

Draft Stem Cell Guidelines Please Many, Disappoint Some |

NIH announces draft stem-cell guidelines: US agency outlines framework for funding human embryonic stem-cell work. |

iPS cell technology gains momentum in drug discovery |

ISSCR: Executive Note: ISSCR Board of Directors and Officers Election Results |

Stem-cell therapy faces more scrutiny in China |

US regulator wades into stem cell therapies for heart disease |

India's first true stem cell trials |

Another look at “Stem cell fate dictated solely by altered nanotube dimension” |

Reply to von der Mark et al.: Looking further into the effects of nanotube dimension on stem cell fate |

US stem-cell research expands: Biomedical agency announces new funding policy for cell lines. |

FDA Regulation of Stem Cell–Based Products |

Medical Innovation Versus Stem Cell Tourism |

The NIH Draft Guidelines on Human Stem Cell Research |

Researchers Generally Happy With Final Stem Cell Rules |

Stem cells: The stress of forming blood cells |

Chief scientist quits California stem-cell agency: Departure raises questions over leadership at flagship centre. |

Italians sue over stem cells: Government's exclusion of human embryonic cells from funding call sparks anger. |

iZumi's plans to capitalize on iPS cells |

Irving Weissman: ISSCR's President-Elect |

NIH draft seen as 'working compromise' |

Stem-cell therapies closer to the clinic: Human induced pluripotent stem cells made without addition of genes. |

Stem Cells: Micro-reprogramming |

Stem-cell clarity: The NIH guidelines on stem-cell research are a good first step, but some revision is needed. |

We must reverse the Bush legacy of stem-cell problems |

Diabetes stem-cell treatment looks to cell capsules |

Sperm-like cells made from human embryonic stem cells |

Mice made from induced stem cells |

Balancing Work and Life: A Conversation with George Daley |

Stem cell: what's in a name? |

The cell that might save sight |

A good nose for stem cells |

Stem cells and a cure for type 1 diabetes? |

Opinion and Commentary |

ES Cell Training Courses |

Snake Oil "Therapeutics" |

Links |

About Us |

Note: ads are provided randomly by Google. The Stem Cell Community curators do not endorse any claims made by these advertisers.

Home > Community Information > Archives > All Archived Articles > Embryonic stem-cell culture...

register | login |

June 02, 2007
FEATURED REVIEW: Embryonic stem-cell culture as a tool for developmental cell biology
ABSTRACT: The cell biology of the early processes of mammalian embryogenesis, such as germ-layer formation, has been technically challenging to study owing to the size and accessibility of mammalian embryos. Embryonic stem cells, which can generate the three germ layers in vitro, are useful for studying embryogenesis at the cellular level. So, how can the study of embryonic stem cells and their differentiation provide a deeper understanding of the cell biology of early development?... - Shin-Ichi Nishikawa, Lars Martin Jakt & Takumi Era Read More...
NATURE REVIEWS CELL BIOLOGY PERSPECTIVES

Printer Friendly Version